Annual Book Value
$237.09 M
+$230.31 M+21.31%
31 December 2023
Summary:
Prelude Therapeutics Incorporated annual book value is currently $237.09 million, with the most recent change of +$230.31 million (+21.31%) on 31 December 2023. During the last 3 years, it has risen by +$24.91 million (+11.74%). PRLD annual book value is now -17.07% below its all-time high of $285.90 million, reached on 31 December 2021.PRLD Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Book Value
$156.43 M
-$25.84 M-14.18%
30 September 2024
Summary:
Prelude Therapeutics Incorporated quarterly book value is currently $156.43 million, with the most recent change of -$25.84 million (-14.18%) on 30 September 2024. Over the past year, it has dropped by -$81.83 million (-34.34%). PRLD quarterly book value is now -56.13% below its all-time high of $356.57 million, reached on 31 March 2021.PRLD Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRLD Book Value Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +21.3% | -34.3% |
3 y3 years | +11.7% | -49.7% |
5 y5 years | +1144.8% | - |
PRLD Book Value High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -17.1% | +21.3% | -49.7% | at low |
5 y | 5 years | -17.1% | +579.8% | -56.1% | +325.7% |
alltime | all time | -17.1% | +579.8% | -56.1% | +325.7% |
Prelude Therapeutics Incorporated Book Value History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $156.43 M(-14.2%) |
June 2024 | - | $182.28 M(-13.5%) |
Mar 2024 | - | $210.73 M(-11.1%) |
Dec 2023 | $237.09 M(+21.3%) | $237.09 M(-0.5%) |
Sept 2023 | - | $238.26 M(-9.1%) |
June 2023 | - | $262.06 M(+49.5%) |
Mar 2023 | - | $175.30 M(-10.3%) |
Dec 2022 | $195.44 M | $195.44 M(-10.1%) |
Sept 2022 | - | $217.41 M(-9.7%) |
June 2022 | - | $240.84 M(-8.0%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $261.81 M(-8.4%) |
Dec 2021 | $285.90 M(+34.7%) | $285.90 M(-8.1%) |
Sept 2021 | - | $311.24 M(-6.9%) |
June 2021 | - | $334.36 M(-6.2%) |
Mar 2021 | - | $356.57 M(+68.0%) |
Dec 2020 | $212.18 M(-529.4%) | $212.18 M(-7.1%) |
Sept 2020 | - | $228.31 M(-429.4%) |
June 2020 | - | -$69.31 M(+40.3%) |
Dec 2019 | -$49.41 M(+117.7%) | -$49.41 M |
Dec 2018 | -$22.69 M | - |
FAQ
- What is Prelude Therapeutics Incorporated annual book value?
- What is the all time high annual book value for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated annual book value year-on-year change?
- What is Prelude Therapeutics Incorporated quarterly book value?
- What is the all time high quarterly book value for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated quarterly book value year-on-year change?
What is Prelude Therapeutics Incorporated annual book value?
The current annual book value of PRLD is $237.09 M
What is the all time high annual book value for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high annual book value is $285.90 M
What is Prelude Therapeutics Incorporated annual book value year-on-year change?
Over the past year, PRLD annual book value has changed by +$41.65 M (+21.31%)
What is Prelude Therapeutics Incorporated quarterly book value?
The current quarterly book value of PRLD is $156.43 M
What is the all time high quarterly book value for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high quarterly book value is $356.57 M
What is Prelude Therapeutics Incorporated quarterly book value year-on-year change?
Over the past year, PRLD quarterly book value has changed by -$81.83 M (-34.34%)